- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Banking and Institutional Finance
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Mergers and Acquisitions (M&A)
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations
- Private Equity
- Public Companies
- Real Estate
- Structured Finance and Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Antitrust
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy Transition
- Energy
- Financial Services
- Food and Beverage
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- Artificial Intelligence and Machine Learning
- Buy American
- Crisis Management
- Doing Business in Latin America
- Environmental Agenda
- Environmental, Social and Governance (ESG)
- Focus on Women's Health
- Russia/Ukraine
- Special Purpose Acquisition Companies (SPACs)
- Careers
- News & Insights
- About
- Languages
News 417 results
Recognition
December 1, 2023
M&A Advisor Honors King & Spalding With Healthcare/Life Sciences Deal of the Year Award
Recognition
November 15, 2023
King & Spalding Once Again Receives Novartis’ “Excellence in Litigation” Award
In the News · Source: Law360
In the News · Source: Law360
In the News · Source: Bloomberg Law
In the News · Source: Law360
Recognition
September 21, 2023
LMG Life Sciences Recognizes King & Spalding With Multiple Rankings in its 2023 Guide
In the News · Source: Law360, Daily Business Review, Daily Report, STAT and Top Class Actions
In the News · Source: The Washington Post, Reuters, The Pink Sheet Citeline Regulatory and Bloomberg Law
September 15, 2023
Jeff Bucholtz counsels the U.S. Chamber of Commerce on its challenge over a provision in the Inflation Reduction Act that allows Medicare to negotiate drugs prices
Recognition
September 8, 2023
LMG Life Sciences Honors King & Spalding as its Government Investigations Firm of the Year and Non-IP Impact Case of Year – United States
In the News · Source: Global Legal Chronicle
September 6, 2023
K&S advises TransMedics on its acquisition of Summer Aviation